Drug major Sun Pharma on Tuesday said the company has reached an agreement with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, to resolve the patent litigation regarding generic version of Revlimid (lenalidomide capsules) in the US. Revlimid is used in the treatment of cancer.

"

 NSE 0.25 % along with one of its wholly-owned subsidiaries today announced that they have reached an ag ..